In vitro and in vivo equivalence of two oral atenolol tablet formulations

Arzneimittel-Forschung/Drug Research

Volumn 52, Issue 5, 2002, Pages 371-378

  Cuadrado, Antonio ^a   Rodríguez Gascón, Alicia ^a   Hernández, Rosa María ^a   Castilla, Ana María ^a   De la Maza, Ane ^a   López de Ocáriz, Alicia ^a   Calvo, Begoña ^a   Pedraz, José Luis ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Atenolol CINFA ; Atenolol, bioavailability, bioequivalence, pharmacokinetics; CAS 29122 68 7

Indexed keywords

ATENOLOL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSAGE FORM; DRUG RELEASE; DRUG SOLUBILITY; FEMALE; HEART RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TABLET FORMULATION; VOLUNTEER;

EID: 0036114013     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1299900     Document Type: Article

References (23)

1. Atenolol: A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders
2. Studies on the pharmacokinetics and pharmacodynamics of atenolol in man
3. Atenolol: A review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension
4. Clinical pharmacokinetics of atenolol: A review
5. Steadystate fluctuation and variability of betaxolol and atenolol plasma levels
6. Mathematical comparison of dissolution profiles
7. Comparative pharmacokinetics of two brands of atenolol following a single oral administration
8. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability
9. On the assesment of bioequivalence in a two-period crossover design
10. Statistical analysis of bioavailability studies: Parametric and nonparametric confidence intervals
11. Generalization of distribution-free confidence intervals for bioavailability ratios
12. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability
13. max for absorption rates in investigations of bioequivalence
14. Updates of bioequivalence programs (including statistical power approximated by Student's t)
15. Comparative bioavailability of two atenolol tablets formulations in healthy male volunteers after a single dose administration
16. Human pharmacokinetic and pharmacodynamic studies on atenolol (ICI 66,082), a new cardioselective beta-adrenoreceptor blocking drug